Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 2
Submit an article Journal homepage
71
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Prognostic impact of cN-III mRNA expression on overall survival and drug sensitivity in pediatric leukemia

Carine Domenecha Institut d’Hématologie et d’Oncologie Pédiatrique, Lyon, France;b Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Lyon, France;c Hospices Civils de Lyon, Lyon, FranceView further author information
,
Adriana Plesab Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Lyon, France;c Hospices Civils de Lyon, Lyon, FranceView further author information
,
Anne Touretteb Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Lyon, FranceView further author information
,
Yves Bertranda Institut d’Hématologie et d’Oncologie Pédiatrique, Lyon, France;c Hospices Civils de Lyon, Lyon, France;d Univ Lyon, Université Claude Bernard, Lyon 1, FranceView further author information
,
Arthur Donya Institut d’Hématologie et d’Oncologie Pédiatrique, Lyon, FranceView further author information
,
Charles Dumontetb Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Lyon, France;c Hospices Civils de Lyon, Lyon, FranceView further author information
,
Emeline Cros-Perrialb Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Lyon, FranceView further author information
&
Lars P. Jordheimb Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Lyon, FranceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3948-7090View further author information
ORCID Icon show all
Pages 457-462 | Received 19 Mar 2021, Accepted 01 Oct 2021, Published online: 18 Oct 2021

References

  • Clavel J, Goubin A, Auclerc MF, et al. Incidence of childhood leukaemia and non-Hodgkin's lymphoma in France: National registry of childhood leukaemia and lymphoma, 1990-1999. Eur J Cancer Prev. 2004;13(2):97–103.
  • Obata T, Endo Y, Murata D, et al. The molecular targets of antitumor 2'-deoxycytidine analogues. Curr Drug Targets. 2003;4(4):305–313.
  • Sampath D, Rao VA, Plunkett W. Mechanisms of apoptosis induction by nucleoside analogs. Oncogene. 2003;22(56):9063–9074.
  • Jordheim LP, Chaloin L. Therapeutic perspectives for cN-II in cancer. Curr Med Chem. 2013;20(34):4292–4303.
  • Bianchi V, Spychala J. Mammalian 5'-nucleotidases. J Biol Chem. 2003;278(47):46195–46198.
  • Jordheim LP, Guittet O, Lepoivre M, et al. Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cells. Mol Cancer Ther. 2005;4(8):1268–1276.
  • Li L, Fridley B, Kalari K, et al. Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression. Cancer Res. 2008;68(17):7050–7058.
  • Aksoy P, Zhu MJ, Kalari KR, et al. Cytosolic 5'-nucleotidase III (NT5C3): gene sequence variation and functional genomics. Pharmacogenet Genomics. 2009;19(8):567–576.
  • Galmarini C, Cros E, Thomas X, et al. The prognostic value of cN-II and cN-III enzymes in adult acute myeloid leukemia. Haematologica. 2005;90(12):1699–1701.
  • Stam RW, den Boer ML, Meijerink JPP, et al. Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia. Blood. 2003;101(4):1270–1276.
  • Stammler G, Zintl F, Sauerbrey A, et al. Deoxycytidine kinase mRNA expression in childhood acute lymphoblastic leukemia. Anticancer Drugs. 1997;8(5):517–521.
  • Galmarini C, Thomas X, Graham K, et al. Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine. Br J Haematol. 2003;122(1):53–60.
  • Pieters R, Veerman AJ. The role of 5'nucleotidase in therapy-resistance of childhood leukemia. Med Hypotheses. 1988;27(1):77–80.
  • Galmarini C, Thomas X, Calvo F, et al. In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia. Br J Haematol. 2002;117(4):860–868.
  • Macanas-Pirard P, Broekhuizen R, Gonzalez D, et al. Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome. Oncotarget. 2017;8(14):23073–23086.
  • van der Velden VHJ, Cazzaniga G, Schrauder A, et al.; European Study Group on MRD detection in ALL (ESG-MRD-ALL). Analysis of minimal residual disease by Ig/TCR gene rearrangements: Guidelines for interpretation of real-time quantitative PCR data. Leukemia. 2007;21(4):604–611.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.